Daewoong Pharmaceutical Presents Phase 2 Clinical Trial Poster on 'Bersiporocin' at ATS 2025, Highlights Global Patient Demographics

Daewoong Pharmaceutical Co., Ltd. South Korea United States of America

View original content:https://www.prnewswire.co.uk/news-releases/daewoong-pharmaceutical-presents-phase-2-clinical-trial-poster-on-bersiporocin-at-ats-2025-highlights-global-patient-demographics-302470702.html